U.S. Markets close in 1 hr 29 mins

FDA pilot program could help Wave avoid orphan-drug pitfalls

Allison DeAngelis
FDA pilot program could help Wave avoid orphan-drug pitfalls

Wave will work with FDA officials during the pilot program to design a Phase 2-3 clinical trial with a reduced number of placebo patients, tweaking standards that have stymied other rare disease products.